Longevity Health Holdings, Inc. (XAGE) shareholders
Close on Oct 19, 2026Market cap $277.24KP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| William R. Newlin Joint filing with Newlin Investment Company 1, LLC (6.10%) | 1,279,941 | 6.10% | 13G (passive) amendment | Dec 31, 2024 |
| International Capital Partners LLC Joint filing with Ajjarapu J. Ram (27.90%) | 689,656 | 27.90% | 13D (active) | Mar 16, 2026 |
| UBS O'Connor LLC | – | – | 13G (passive) amendment | Dec 29, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XAGE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| DRW Securities, LLC | 14,154 | – | $3.68K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 2 | 0M | 2 / 0 | 0 / 10 | 0M | 0M |
| Q2 2025 | 10 | 0M | 10 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| J. Ram Ajjarapu | Chief Executive Officer, Director, 10% owner | 689,656 | Apr 8, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| J. Ram Ajjarapu Chief Executive Officer, Director, 10% owner | Mar 16, 2026 | Buy | +689,656 | $0.29 | $200.00K | 689,656 |
| Richard A. Upton Director | Sep 13, 2024 | Buy | +5,000 | $0.47 | $2.35K | 15,000 |
| Bryan J. Cassaday Chief Financial Officer | Sep 10, 2024 | Buy | +475 | $0.46 | $219 | 4,250 |
| Scott M. Frisch Director | Sep 6, 2024 | Buy | +1,009 | $0.51 | $515 | 7,598 |
| Kathryn Gregory Director | Sep 6, 2024 | Buy | +1,260 | $0.51 | $643 | 22,500 |
| Gilles Spenlehauer Director | Sep 6, 2024 | Buy | +1,009 | $0.51 | $515 | 7,598 |
| Patrick A. Sturgeon Director | Sep 6, 2024 | Buy | +1,261 | $0.51 | $643 | 18,051 |
| Kathryn Gregory Director | Aug 30, 2024 | Buy | +109 | $0.57 | $62 | 21,240 |
| Gilles Spenlehauer Director | Aug 30, 2024 | Buy | +87 | $0.57 | $50 | 6,589 |
| Scott M. Frisch Director | Aug 30, 2024 | Buy | +87 | $0.57 | $50 | 6,589 |
| Patrick A. Sturgeon Director | Aug 30, 2024 | Buy | +109 | $0.57 | $62 | 16,790 |
| Scott M. Frisch Director | Aug 29, 2024 | Buy | +522 | $0.56 | $292 | 6,502 |
| Patrick A. Sturgeon Director | Aug 29, 2024 | Buy | +652 | $0.56 | $365 | 16,681 |
| Kathryn Gregory Director | Aug 29, 2024 | Buy | +652 | $0.56 | $365 | 21,131 |
| David W. Anderson Director | Aug 29, 2024 | Buy | +652 | $0.56 | $365 | 8,128 |
| Bryan J. Cassaday Chief Financial Officer | Aug 29, 2024 | Buy | +1,000 | $0.57 | $570 | 3,775 |
| Gilles Spenlehauer Director | Aug 29, 2024 | Buy | +522 | $0.56 | $292 | 6,502 |
| Scott M. Frisch Director | Aug 28, 2024 | Buy | +599 | $0.56 | $335 | 5,980 |
| Patrick A. Sturgeon Director | Aug 28, 2024 | Buy | +970 | $0.56 | $543 | 16,029 |
| Kathryn Gregory Director | Aug 28, 2024 | Buy | +1,084 | $0.56 | $607 | 20,479 |
| David W. Anderson Director | Aug 28, 2024 | Buy | +749 | $0.56 | $419 | 7,476 |
| Gilles Spenlehauer Director | Aug 28, 2024 | Buy | +599 | $0.56 | $335 | 5,980 |
| Patrick A. Sturgeon Director | Aug 27, 2024 | Buy | +1,587 | $0.71 | $1.13K | 15,059 |
| Kathryn Gregory Director | Aug 27, 2024 | Buy | +2,413 | $0.71 | $1.71K | 19,395 |
| Patrick A. Sturgeon Director | Aug 26, 2024 | Buy | +1,587 | $0.72 | $1.14K | 13,472 |
| Kathryn Gregory Director | Aug 26, 2024 | Buy | +2,413 | $0.72 | $1.74K | 16,981 |
| Patrick A. Sturgeon Director | Aug 23, 2024 | Buy | +1,587 | $0.72 | $1.14K | 11,885 |
| Kathryn Gregory Director | Aug 23, 2024 | Buy | +2,413 | $0.72 | $1.74K | 14,568 |
| Kathryn Gregory Director | Aug 22, 2024 | Buy | +2,413 | $0.72 | $1.74K | 12,156 |
| Patrick A. Sturgeon Director | Aug 21, 2024 | Buy | +1,984 | $0.08 | $159 | 8,711 |
| Kathryn Gregory Director | Aug 21, 2024 | Buy | +3,016 | $0.79 | $2.38K | 9,743 |
| Richard A. Upton Director | Aug 20, 2024 | Buy | +3,600 | $0.89 | $3.20K | 10,000 |
| Richard A. Upton Director | Jun 12, 2024 | Buy | +2,000 | $2.20 | $4.40K | 6,400 |
| Bryan J. Cassaday Chief Financial Officer | Jun 10, 2024 | Buy | +440 | $2.50 | $1.10K | 2,775 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | Jun 6, 2024 | Buy | +2,100 | $2.63 | $5.52K | 72,103 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 30, 2024 | Buy | +2,000 | $2.50 | $5.00K | 70,003 |
| Bryan J. Cassaday Chief Financial Officer | May 30, 2024 | Buy | +365 | $2.55 | $931 | 2,335 |
| Bryan J. Cassaday Chief Financial Officer | May 29, 2024 | Buy | +30 | $2.60 | $78 | 1,970 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 28, 2024 | Buy | +20 | $2.57 | $51 | 68,003 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 24, 2024 | Buy | +1,939 | $2.57 | $4.98K | 67,983 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 23, 2024 | Buy | +2,100 | $2.50 | $5.25K | 66,044 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 22, 2024 | Buy | +4,051 | $2.41 | $9.76K | 63,944 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 21, 2024 | Buy | +1,515 | $2.39 | $3.62K | 59,893 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | May 20, 2024 | Buy | +1,172 | $2.22 | $2.60K | 58,378 |
| Rajiv Shukla Chairman and CEO, Director, 10% owner | Apr 4, 2024 | Buy | +8,680 | $2.88 | $25.00K | 57,206 |
| Patrick A. Sturgeon Director | Dec 15, 2023 | Buy | +1,587 | $0.72 | $1.14K | 10,298 |
| Patrick A. Sturgeon Director | Dec 15, 2023 | Buy | +739 | $3.94 | $2.91K | 6,727 |
| David W. Anderson Director | Dec 15, 2023 | Buy | +739 | $3.94 | $2.91K | 6,727 |
| Gilles Spenlehauer Director | Dec 15, 2023 | Buy | +591 | $3.94 | $2.33K | 5,381 |
| Kathryn Gregory Director | Dec 15, 2023 | Buy | +739 | $3.94 | $2.91K | 6,727 |
| Scott M. Frisch Director | Dec 15, 2023 | Buy | +591 | $3.94 | $2.33K | 5,381 |
| Bryan J. Cassaday Chief Financial Officer | Dec 14, 2023 | Buy | +440 | $3.50 | $1.54K | 1,940 |
| Patrick A. Sturgeon Director | Dec 14, 2023 | Buy | +391 | $3.61 | $1.41K | 5,988 |
| David W. Anderson Director | Dec 14, 2023 | Buy | +391 | $3.61 | $1.41K | 5,988 |
| Gilles Spenlehauer Director | Dec 14, 2023 | Buy | +313 | $3.61 | $1.13K | 4,790 |
| Kathryn Gregory Director | Dec 14, 2023 | Buy | +391 | $3.61 | $1.41K | 5,988 |
| Scott M. Frisch Director | Dec 14, 2023 | Buy | +313 | $3.61 | $1.13K | 4,790 |
| Kathryn Gregory Director | Dec 13, 2023 | Buy | +1,087 | $5.57 | $6.05K | 5,597 |
| Patrick A. Sturgeon Director | Dec 13, 2023 | Buy | +1,087 | $5.57 | $6.05K | 5,597 |
| David W. Anderson Director | Dec 13, 2023 | Buy | +1,087 | $5.57 | $6.05K | 5,597 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Longevity Health's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?